Antitumour activity of a potent MEK inhibitor RDEA119/BAY 869766 combined with rapamycin in human orthotopic primary pancreatic cancer xenografts

Overview of attention for article published in BMC Cancer, September 2010

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
Good Attention Score compared to outputs of the same age (72nd percentile)
Good Attention Score compared to outputs of the same age and source (78th percentile)

Mentioned by

patent: 2 patents

Citations

dimensions_citation: 32 Dimensions

Readers on

mendeley: 29 Mendeley

Summary Patents Dimensions citations

So far, Altmetric has seen 2 patents that reference this research output.

Combination therapy for the treatment of pancreatic cancer

Grant US-10933058-B2

United States of America

COMBINATION THERAPY FOR THE TREATMENT OF PANCREATIC CANCER

Application WO-2018039211-A1

World Intellectual Property Organisation (WIPO)

This page shows the most recent patents that mention this research output.

Click here to find out how to access more activity.